Preclinical Safety Evaluation of Monoclonal Antibodies
George Treacy, Pauline L. Martin
Abstract
George Treacy, Pauline L. Martin
Abstract
Abstract Monoclonal antibodies are populations of identical, monospecific antibodies with defined specificity and affinity for a target antigen. The design of preclinical safety evaluation of monoclonal antibodies is based on the class of monoclonal, the target epitope, and the clinical indication. This article focuses on preclinical safety evaluation of monoclonal antibodies.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract Monoclonal antibodies are populations of identical, monospecific antibodies with defined specificity and affinity for a target antigen. The design of preclinical safety evaluation of monoclonal antibodies is based on the class of monoclonal, the target epitope, and the clinical indication. This article focuses on preclinical safety evaluation of monoclonal antibodies.
Key concepts: Monoclonal antibody, Epitope, Antibody, Monoclonal, Antigen, Medicine, Immunology